By expenditures
| Name | Title | Type |
|---|---|---|
| Joel Rusco | Chief Financial Officer | Auditee |
| Jacy Hyde | Executive Director | Auditee |
| Jessica Andersen | Partner | Auditee |
| Ryan Mcdonald | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 365313 | 2024 | 2025-08-29 | Cliftonlarsonallen LLP | $1.93M |
| 352771 | 2023 | 2025-04-04 | Cliftonlarsonallen LLP | $2.88M |
| 352633 | 2022 | 2025-04-03 | Cliftonlarsonallen LLP | $2.79M |
| 305892 | 2021 | 2024-05-09 | Eide Bailly LLP | $2.67M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 365313 | 2024 | 2025-08-29 | 1151734 | 2024-005 | Significant Deficiency | - | AB |
| 365313 | 2024 | 2025-08-29 | 1151733 | 2024-004 | Material Weakness | - | I |
| 365313 | 2024 | 2025-08-29 | 1151732 | 2024-003 | Material Weakness | Yes | M |
| 365313 | 2024 | 2025-08-29 | 1151731 | 2024-002 | Material Weakness | Yes | I |
| 365313 | 2024 | 2025-08-29 | 575292 | 2024-005 | Significant Deficiency | - | AB |
| 365313 | 2024 | 2025-08-29 | 575291 | 2024-004 | Material Weakness | - | I |
| 365313 | 2024 | 2025-08-29 | 575290 | 2024-003 | Material Weakness | Yes | M |
| 365313 | 2024 | 2025-08-29 | 575289 | 2024-002 | Material Weakness | Yes | I |
| 352771 | 2023 | 2025-04-04 | 1130560 | 2023-005 | Material Weakness | Yes | M |
| 352771 | 2023 | 2025-04-04 | 1130559 | 2023-004 | Material Weakness | Yes | I |
| 352771 | 2023 | 2025-04-04 | 554118 | 2023-005 | Material Weakness | Yes | M |
| 352771 | 2023 | 2025-04-04 | 554117 | 2023-004 | Material Weakness | Yes | I |
| 352633 | 2022 | 2025-04-03 | 1130439 | 2022-010 | Material Weakness | Yes | B |
| 352633 | 2022 | 2025-04-03 | 1130438 | 2022-009 | Material Weakness | Yes | M |
| 352633 | 2022 | 2025-04-03 | 1130437 | 2022-008 | Material Weakness | - | M |
| 352633 | 2022 | 2025-04-03 | 1130436 | 2022-007 | Significant Deficiency | Yes | L |
| 352633 | 2022 | 2025-04-03 | 1130435 | 2022-006 | Significant Deficiency | Yes | A |
| 352633 | 2022 | 2025-04-03 | 1130434 | 2022-005 | Significant Deficiency | - | M |
| 352633 | 2022 | 2025-04-03 | 1130433 | 2022-004 | Significant Deficiency | Yes | A |
| 352633 | 2022 | 2025-04-03 | 553997 | 2022-010 | Material Weakness | Yes | B |
| 352633 | 2022 | 2025-04-03 | 553996 | 2022-009 | Material Weakness | Yes | M |
| 352633 | 2022 | 2025-04-03 | 553995 | 2022-008 | Material Weakness | - | M |
| 352633 | 2022 | 2025-04-03 | 553994 | 2022-007 | Significant Deficiency | Yes | L |
| 352633 | 2022 | 2025-04-03 | 553993 | 2022-006 | Significant Deficiency | Yes | A |
| 352633 | 2022 | 2025-04-03 | 553992 | 2022-005 | Significant Deficiency | - | M |
| 352633 | 2022 | 2025-04-03 | 553991 | 2022-004 | Significant Deficiency | Yes | A |
| 305892 | 2021 | 2024-05-09 | 972689 | 2021-010 | Material Weakness | Yes | Cash Management |
| 305892 | 2021 | 2024-05-09 | 972688 | 2021-009 | Material Weakness | Yes | GM |
| 305892 | 2021 | 2024-05-09 | 972687 | 2021-008 | Material Weakness | - | M |
| 305892 | 2021 | 2024-05-09 | 972686 | 2021-007 | Material Weakness | - | L |
| 305892 | 2021 | 2024-05-09 | 972685 | 2021-006 | Material Weakness | - | L |
| 305892 | 2021 | 2024-05-09 | 972684 | 2021-005 | Significant Deficiency | - | AB |
| 305892 | 2021 | 2024-05-09 | 396247 | 2021-010 | Material Weakness | Yes | Cash Management |
| 305892 | 2021 | 2024-05-09 | 396246 | 2021-009 | Material Weakness | Yes | GM |
| 305892 | 2021 | 2024-05-09 | 396245 | 2021-008 | Material Weakness | - | M |
| 305892 | 2021 | 2024-05-09 | 396244 | 2021-007 | Material Weakness | - | L |
| 305892 | 2021 | 2024-05-09 | 396243 | 2021-006 | Material Weakness | - | L |
| 305892 | 2021 | 2024-05-09 | 396242 | 2021-005 | Significant Deficiency | - | AB |